Literature DB >> 7477236

Immunosuppressive therapy for myocarditis.

B Maisch, F Camerini, H P Schultheiss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477236

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  [Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery].

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Herz       Date:  2010-03       Impact factor: 1.443

2.  [In focus: Inflammatory cardiomyopathy].

Authors:  H P Schultheiss
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

Review 3.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

4.  Biomarkers in inflammatory and noninflammatory cardiomyopathy.

Authors:  Michel Noutsias; Sabine Pankuweit; Bernhard Maisch
Journal:  Herz       Date:  2009-12       Impact factor: 1.443

Review 5.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 7.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

Review 8.  [Inflammatory cardiomyopathy and myocarditis].

Authors:  B Maisch; A D Ristic; S Pankuweit
Journal:  Herz       Date:  2017-06       Impact factor: 1.740

9.  [Etiology, diagnosis, management, and treatment of myocarditis. Position paper from the ESC Working Group on Myocardial and Pericardial Diseases].

Authors:  S Pankuweit; B Maisch
Journal:  Herz       Date:  2013-12       Impact factor: 1.740

Review 10.  Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

Authors:  B Maisch; P Alter
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.